Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 1 of 1 for:    MOR107
Previous Study | Return to List | Next Study

First in Human Single Ascending Dose Study of MOR107

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03067363
Recruitment Status : Terminated (Part 1 completed successfully. Part 2 not conducted.)
First Posted : March 1, 2017
Last Update Posted : February 7, 2018
Quotient Clinical
Information provided by (Responsible Party):
Alan Richardson, LanthioPep BV

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 23, 2017
Actual Study Completion Date : March 23, 2017